Results 161 to 170 of about 6,394 (171)

Ranibizumab

Drugs, 2012
Ranibizumab, an intravitreally administered inhibitor of vascular endothelial growth factor (VEGF), is approved for the treatment of visual impairment associated with diabetic macular oedema (DME) in the EU. In four well designed, phase II or III trials (RESOLVE, RESTORE, RIDE and RISE), 1-2 years' treatment with ranibizumab was more effective than ...
openaire   +2 more sources

Macular oedema and retinal neovascularisation in juvenile diabetics

International Ophthalmology, 1992
Thirteen young diabetic patients with peripheral capillary non perfusion who presented with symptoms of mild maculopathy were reviewed retrospectively. In this group, peripheral retinal ischaemia was often overlooked and a rapidly progressive proliferative retinopathy developed. Fluorescein angiography of the peripheral retina showed capillary closure,
P J, Polkinghorne, A I, Uliss, A M, Hamilton   +2 more
openaire   +2 more sources

[Therapeutic possibilities for diabetic macular oedema].

Nederlands tijdschrift voor geneeskunde, 2006
The number of patients with diabetes mellitus will increase over the coming years, so that there will also be more patients with diabetic macular oedema. Diabetic macular oedema and diabetic retinopathy are the most important causes of legal blindness in adults.
N G M, Wiemer, B C P, Polak, M A H, Veckeneer   +2 more
openaire   +1 more source

Cystoid Macular Oedema in Diabetic Retinopathy

1976
In cases of cystoid macular oedema fluorescein angiographic leakage points within the perimacular capillary bed will reveal the origin of serum spreading toward the macula. Diabetic retinopathy being associated with this type of vascular changes will not be amendable to any mode of medical therapy.
H. Freyler, I. Egerer
openaire   +1 more source

[Surgical treatment of diabetic macular oedema].

Klinische Monatsblatter fur Augenheilkunde, 2010
The therapy for diabetic macular oedema often remains unsatisfactory for both patient and treating physician. Therapeutic approaches comprise laser therapy as the evidence-based "basic therapy" and increasingly also intravitreal injections of drugs which, however, have only a limited effect.
M A, Gamulescu, W A, Herrmann, H, Helbig
openaire   +1 more source

[Treatment of diabetic macular oedema].

Vnitrni lekarstvi, 2013
Diabetic macular oedema (DMO) is currently the main complication associated with diabetes. The percentage of patients with DMO grows alongside the increasing number of diabetes occurrences. The DMO treatment has seen major developments in the past few years.
openaire   +1 more source

Laser photocoagulation for diabetic macular oedema

Cochrane Database of Systematic Reviews, 2013
Eliane C Jorge, Edson N Jorge, Regina El Dib   +2 more
openaire   +1 more source

Aflibercept for diabetic macular oedema

The Pharmaceutical Journal, 2015
openaire   +1 more source

Faricimab for treatment of diabetic macular oedema

Practical Diabetes, 2022
openaire   +1 more source

Diabetic Macular Oedema (revision number 13)

2015
openaire   +1 more source